{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:59:24Z","timestamp":1780527564820,"version":"3.54.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The Validated Hemophilia Regimen Treatment Adherence Scale\u2014Prophylaxis (VERITAS-Pro) assesses adherence to prophylaxis treatment recommendations in hemophilia patients. This study aimed to adapt the VERITAS-Pro into Turkish and evaluate its reliability and validity. The research design used is a psychometric study. A convenience sample of 102 patients with hemophilia A or B was followed by the Aegean Adult Hemophilia and Thrombosis Center. The VERITAS-Pro was adapted to Turkish in six steps, including forward- and back-translation, committee review, and reliability and validity analysis. Based on the confirmatory factor analysis, modification indices suggested discrepancies amongst items, which were improved upon the removal of items 11 and 15. Findings from this alternative model are: \u03c7<jats:sup>2<\/jats:sup>\/df = 1.34; RMSEA = 0.05; SRMR = 0.09; and IFI = 0.92. The alternative model showed high adherence rates. Cronbach\u2019s alpha value for the Turkish version was found to be 0.83. The test-retest reliability of the Turkish scale ranged from 0.31 to 0.78. All items discriminated significantly between participants who were more adherent and those who were less adherent (t = 23.53; p&lt;0.01). Translation of the VERITAS-Pro into local languages enables more accurate measurement of treatment adherence among people with hemophilia and facilitates cross-cultural comparison studies. According to the validity and reliability evidence obtained, the psychometric properties of the Turkish version of the VERITAS-Pro are suitable.<\/jats:p>","DOI":"10.1371\/journal.pone.0288625","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T17:30:41Z","timestamp":1691602241000},"page":"e0288625","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adherence to hemophilia patients with prophylaxis: Veritas-Pro and psychometric properties adapted to Turkish"],"prefix":"10.1371","volume":"18","author":[{"given":"Zuhal","family":"Mehrekula Demirci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1305-3035","authenticated-orcid":true,"given":"Nilufer","family":"Demiral Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hale","family":"Bulbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Keklik Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatos Dilan","family":"Atilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guray","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahri","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"issue":"Suppl 6","key":"pone.0288625.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"A Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"6","key":"pone.0288625.ref002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"MJ Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0288625.ref003","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2516.2001.00534.x","article-title":"Barriers to compliance with prophylaxis therapy in haemophilia","volume":"7","author":"MR Hacker","year":"2001","journal-title":"Haemophilia"},{"issue":"2","key":"pone.0288625.ref004","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/0887044031000098198","article-title":"The illness perceptions and treatment beliefs of individuals with severe haemophilia and their role in adherence to home treatment","volume":"18","author":"CD Llewellyn","year":"2003","journal-title":"Psychology and Health"},{"issue":"1","key":"pone.0288625.ref005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/hae.12235","article-title":"An objective method for assessing adherence to prophylaxis in adults with severe haemophilia","volume":"20","author":"S Ho","year":"2014","journal-title":"Haemophilia"},{"issue":"5","key":"pone.0288625.ref006","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2516.2008.01843.x","article-title":"A survey of adherence to haemophilia therapy in six European countries: results and recommendations","volume":"14","author":"P De Moerloose","year":"2008","journal-title":"Haemophilia"},{"issue":"4","key":"pone.0288625.ref007","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1111\/hae.12951","article-title":"Predictors of non\u2010adherence to prescribed prophylactic clotting\u2010factor treatment regimens among adolescent and young adults with a bleeding disorder","volume":"22","author":"M Witkop","year":"2016","journal-title":"Haemophilia"},{"issue":"5","key":"pone.0288625.ref008","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/hae.12660","article-title":"Unravelling adherence to prophylaxis in haemophilia: a patients\u2019 perspective","volume":"21","author":"L Schrijvers","year":"2015","journal-title":"Haemophilia"},{"issue":"3","key":"pone.0288625.ref009","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/hae.12079","article-title":"Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review","volume":"19","author":"L Schrijvers","year":"2013","journal-title":"Haemophilia"},{"issue":"4","key":"pone.0288625.ref010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2516.2012.02756.x","article-title":"Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States","volume":"18","author":"C Thornburg","year":"2012","journal-title":"Haemophilia"},{"issue":"3","key":"pone.0288625.ref011","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1111\/j.1365-2516.2012.02770.x","article-title":"Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey","volume":"18","author":"S Zappa","year":"2012","journal-title":"Haemophilia"},{"issue":"2","key":"pone.0288625.ref012","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2516.2009.02129.x","article-title":"VERITAS\u2010Pro: a new measure of adherence to prophylactic regimens in haemophilia","volume":"16","author":"N Duncan","year":"2010","journal-title":"Haemophilia"},{"issue":"2","key":"pone.0288625.ref013","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1111\/hae.12054","article-title":"Cross\u2010cultural adaptation and linguistic validation of age\u2010group\u2010specific haemophilia patient\u2010reported outcome (PRO) instruments for patients and parents","volume":"19","author":"S Von Mackensen","year":"2013","journal-title":"Haemophilia"},{"issue":"2","key":"pone.0288625.ref014","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2753.2010.01434.x","article-title":"Translation, adaptation and validation of instruments or scales for use in cross\u2010cultural health care research: a clear and user\u2010friendly guideline","volume":"17","author":"VD Sousa","year":"2011","journal-title":"Journal of evaluation in clinical practice"},{"issue":"4","key":"pone.0288625.ref015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/07481756.2005.11909764","article-title":"Assessing goodness of fit in confirmatory factor analysis","volume":"37","author":"J. Sun","year":"2005","journal-title":"Measurement and evaluation in counseling and development"},{"key":"pone.0288625.ref016","volume-title":"Principles and practice of structural equation modelling: Methodology in the social sciences","author":"R Kline","year":"2005","edition":"2"},{"key":"pone.0288625.ref017","volume-title":"Using LISREL for structural equation modeling: A researcher\u2019s guide","author":"EK Kelloway","year":"1998"},{"issue":"1","key":"pone.0288625.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10705519909540118","article-title":"Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives","volume":"6","author":"Hu Lt","year":"1999","journal-title":"Structural equation modeling: a multidisciplinary journal"},{"key":"pone.0288625.ref019","author":"SG West","year":"1995","journal-title":"Structural equation models with nonnormal variables: Problems and remedies"},{"issue":"10","key":"pone.0288625.ref020","doi-asserted-by":"crossref","first-page":"e0259062","DOI":"10.1371\/journal.pone.0259062","article-title":"Validity and reliability of the Serbian COVID Stress Scales","volume":"16","author":"M Milic","year":"2021","journal-title":"PLoS One"},{"key":"pone.0288625.ref021","author":"C. Wife","year":"2018","journal-title":"Adherence to prophylaxis and bleeding outcome in children and adolescents with severe haemophilia"},{"key":"pone.0288625.ref022","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/PPA.S126828","article-title":"Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia","author":"R Cuesta-Barriuso","year":"2017","journal-title":"Patient preference and adherence"},{"key":"pone.0288625.ref023","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bjhh.2017.09.002","article-title":"Validation of the Brazilian version of the VERITAS-Pro scale to assess adherence to prophylactic regimens in hemophilia","volume":"40","author":"AA Ferreira","year":"2018","journal-title":"Hematology, Transfusion and Cell Therapy"},{"key":"pone.0288625.ref024","volume-title":"A treatment manual for healthcare workers","author":"R. Gray","year":"2011"},{"key":"pone.0288625.ref025","volume-title":"Adherence to long-term therapies: evidence for action","author":"WH Organization","year":"2003"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T20:06:17Z","timestamp":1702929977000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288625"}},"subtitle":[],"editor":[{"given":"Fatih","family":"\u00d6zden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0288625","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]}}}